In a recent Compliance Week article, Keri Bruce and Kevin Madagan discuss the FTC’s and FDA’s increased attention to disclosure practices, reminding companies to review their existing measures.  The article underscores the importance for companies to reeducate themselves and reevaluate approval processes to help avoid enforcement.